Kyle Wright
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 10
- CAR-T cell therapy research 4
- Cancer Immunotherapy and Biomarkers 4
-
- Immune Cell Function and Interaction 3
- Immunodeficiency and Autoimmune Disorders 2
- Immune Response and Inflammation 2
- Co-authors
- Scott J. Rodig (3 shared papers)Philippe A. Armand (2 shared papers)Reid W. Merryman (1 shared paper)Anthony T. Vella (4 shared papers)Jason L. Weirather (2 shared papers)Adrian I Bot (1 shared paper)Caron Alyce Jacobson (1 shared paper)William Y. Go (1 shared paper)
- Journals
- Blood Advances (4 papers)Journal of Clinical Oncology (1 paper)Infection and Immunity (1 paper)Journal of Clinical Investigation (1 paper)American Journal of Hematology (1 paper)
- Partner nations
- United StatesDenmark
In The Last Decade
Kyle Wright
22 papers receiving 790 citations
Peers
Comparison fields: 5 of 67
- Oncology 532
- Pathology and Forensic Medicine 183
- Immunology 208
- Genetics 45
- Periodontics 18
Countries citing papers authored by Kyle Wright
This map shows the geographic impact of Kyle Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle Wright more than expected).
Fields of papers citing papers by Kyle Wright
This network shows the impact of papers produced by Kyle Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle Wright. The network helps show where Kyle Wright may publish in the future.
Co-authors
The 25 scholars most cited alongside Kyle Wright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 290 | |
| 2 | 2017 | 94 | |
| 3 | 2020 | 88 | |
| 4 | 2013 | 66 | |
| 5 | 2020 | 40 | |
| 6 | 2017 | 32 | |
| 7 | 2019 | 28 | |
| 8 | 2022 | 25 | |
| 9 | 2013 | 25 | |
| 10 | Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group study. | 2000 | 24 |
| 11 | 2023 | 22 | |
| 12 | 2019 | 21 | |
| 13 | 2020 | 11 | |
| 14 | 2020 | 11 | |
| 15 | 2024 | 6 | |
| 16 | 2020 | 5 | |
| 17 | 2023 | 5 | |
| 18 | 2014 | 5 | |
| 19 | 2019 | 2 | |
| 20 | 2023 | 1 |
About Kyle Wright
Kyle Wright is a scholar working on Oncology, Immunology, Pathology and Forensic Medicine, Genetics and Hematology, having authored 24 papers that have together received 803 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Immune Cell Function and Interaction (3 papers), Fungal Infections and Studies (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Inflammasome and immune disorders (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Oncology (532 citations), Pathology and Forensic Medicine (183 citations), Immunology (208 citations), Genetics (45 citations) and Periodontics (18 citations). Kyle Wright has collaborated with scholars based in United States and Denmark. Frequent co-authors include Scott J. Rodig, Philippe A. Armand, Reid W. Merryman, Anthony T. Vella, Jason L. Weirather, Adrian I Bot, Caron Alyce Jacobson, William Y. Go, Mikel Lipschitz and Pei-Hsuan Chen. Their work appears in journals such as Blood Advances, Journal of Clinical Oncology, Infection and Immunity, Journal of Clinical Investigation and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.